IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells

J Immunol. 2005 May 1;174(9):5261-9. doi: 10.4049/jimmunol.174.9.5261.

Abstract

Human telomerase activity is induced by Ag receptor ligation in T and B cells. However, it is unknown whether telomerase activity is increased in association with activation and proliferation of NK cells. We found that telomerase activity in a human NK cell line (NK-92), which requires IL-2 for proliferation, was increased within 24 h after stimulation with IL-2. Levels of human telomerase reverse transcriptase (hTERT) mRNA and protein correlated with telomerase activity. ERK1/2 and Akt kinase (Akt) were activated by IL-2 stimulation. LY294002, an inhibitor of PI3K, abolished expression of hTERT mRNA and protein expression and abolished hTERT activity, whereas PD98059, which inhibits MEK1/2 and thus ERK1/2, had no effect. In addition, radicicol, an inhibitor of heat shock protein 90 (Hsp90), and rapamycin, an inhibitor of the mammalian target of rapamycin (mTOR), blocked IL-2-induced hTERT activity and nuclear translocation of hTERT but not hTERT mRNA expression. hTERT was coimmunoprecipitated with Akt, Hsp90, mTOR, and p70 S6 kinase (S6K), suggesting that these molecules form a physical complex. Immunoprecipitates of Akt, Hsp90, mTOR, and S6K from IL-2-stimulated NK-92 cells contained telomerase activity. Furthermore, the findings that Hsp90 and mTOR immunoprecipitates from primary samples contained telomerase activity are consistent with the results from NK-92 cells. These results indicate that IL-2 stimulation induces hTERT activation and that the mechanism of IL-2-induced hTERT activation involves transcriptional or posttranslational regulation through the pathway including PI3K/Akt, Hsp90, mTOR, and S6K in NK cells.

MeSH terms

  • Cell Line, Transformed
  • Chromones / pharmacology
  • DNA-Binding Proteins
  • Enzyme Inhibitors / pharmacology
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Flavonoids / pharmacology
  • HSP90 Heat-Shock Proteins / physiology*
  • Humans
  • Interleukin-2 / antagonists & inhibitors
  • Interleukin-2 / physiology*
  • Killer Cells, Natural / enzymology*
  • Killer Cells, Natural / immunology
  • Killer Cells, Natural / metabolism
  • Lactones / pharmacology
  • Leukemia, Lymphocytic, Chronic, B-Cell / enzymology
  • Leukemia, Lymphoid / enzymology
  • Lymphocyte Activation / immunology
  • Macrolides
  • Morpholines / pharmacology
  • Phosphatidylinositol 3-Kinases / physiology*
  • Protein Kinases / physiology*
  • Protein Processing, Post-Translational / immunology*
  • Protein Serine-Threonine Kinases / metabolism
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-akt
  • RNA-Directed DNA Polymerase / metabolism*
  • Ribosomal Protein S6 Kinases, 70-kDa / metabolism
  • Sirolimus / pharmacology
  • TOR Serine-Threonine Kinases
  • Telomerase / antagonists & inhibitors
  • Telomerase / genetics
  • Telomerase / metabolism*
  • Transcription, Genetic / immunology*

Substances

  • Chromones
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • Flavonoids
  • HSP90 Heat-Shock Proteins
  • Interleukin-2
  • Lactones
  • Macrolides
  • Morpholines
  • Proto-Oncogene Proteins
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Protein Kinases
  • MTOR protein, human
  • AKT1 protein, human
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • Ribosomal Protein S6 Kinases, 70-kDa
  • TOR Serine-Threonine Kinases
  • ribosomal protein S6 kinase, 70kD, polypeptide 2
  • Extracellular Signal-Regulated MAP Kinases
  • RNA-Directed DNA Polymerase
  • Telomerase
  • monorden
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
  • Sirolimus